Among all HB patients, those with CTNNB1 mutations ( n = 4) appeared to respond better to platinum-based chemotherapy and showed a trend toward improved outcomes.
← all excerpts
Landscape of Somatic Alterations in Thai Pediatric Hepatoblastoma: Implications for Clinical Outcomes and Therapeutic Opportunities.
1
—
—